TMO Thermo Fisher Scientific Inc falls 295 percent post Q4 2025 earnings despite narrow EPS beat and 39 percent yearoveryear revenue growth Neumora Therapeutics NMRA Stock Turns Bearish on Neumora Therapeutics NMRA 148 20260415 GDEN Golden Entertainment Inc reports steep Q4 2025 EPS miss sending shares down 064 in todays trading Is RingCentral RNG stock outperforming the market 015 20260418 BZFD Q1 2026 Earnings EPS Misses Estimates Stock Declines NGNE Q1 2026 Earnings Earnings Miss Estimates as Pipeline Progress Offsets Financial Headwinds CSR Q1 2026 Earnings Widely Misses EPS Estimates Stock Declines ARCB Q1 2026 Earnings EPS Surprise of 1536 Drives Stock Higher SLMBP Q1 2026 Earnings Preferred Stock Benefits from Strong Underlying Earnings Beat NI Holdings NODK Q4 2022 Earnings Modest Profit in a Challenging Insurance Market